Cara Therapeutics, Inc. 4
4 · Cara Therapeutics, Inc. · Filed Feb 3, 2015
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Sale
Common Stock
2015-02-02$10.60/sh−7,262$76,977→ 358,560 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2014.